·
EDITORIAL
·
Celebrating the 2nd anniversary of Biomaterials Translational
Show Less
1
Institute of Life Science, Swansea University Medical School, Swansea,
UK
2
Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC,
USA
BMT 2022 , 3(4), 235–236;
https://doi.org/10.12336/biomatertransl.2022.04.002
Submitted: 29 December 2022 | Published: 28 December 2022
Copyright © 2022 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution–NonCommercial–ShareAlike 4.0 License.
References
- Giusto, E.; Blunn, G.; de Godoy, R.; Liu, C.; Pendegrass, C. Optimising soft tissue in-growth in vivo in additive layer manufactured osseointegrated transcutaneous implants. Biomater Transl. 2022, 3, 243-249.
- 2. Fan, J.; Pung, E.; Lin, Y.; Wang, Q. Recent development of hydrogen sulfide-releasing biomaterials as novel therapies: a narrative review. Biomater Transl. 2022, 3, 250-263.
- 3. Wang, Y.; Chen, Y.; Wei, Y. Osteoarthritis animal models for biomaterial-assisted osteochondral regeneration. Biomater Transl. 2022, 3, 264-279.
- 4. Yuan, G.; Li, Z.; Lin, X.; Li, N.; Xu, R. New perspective of skeletal stem cells. Biomater Transl. 2022, 3, 280-294.
- 5. Xia, Z. Skeletal interoception: an emerging area for musculoskeletal research. Biomater Transl. 2022, 3, 237-239.
- 6. Guo, H.; Huang, X. Engineered exosomes for future gene-editing therapy. Biomater Transl. 2022, 3, 240-242.
Conflict of interest
The authors declare they have no competing interests.
